Literature DB >> 6833284

Regulation of ligand binding to pituitary D-2 dopaminergic receptors. Effects of divalent cations and functional group modification.

D R Sibley, I Creese.   

Abstract

The effects of divalent cations and protein-modifying reagents on the binding of agonist and antagonist ligands to D-2 dopaminergic receptors were studied. The divalent cations Mg2+, Ca2+, and Mn2+ markedly increase the binding of the agonist [3H]N-n-propylnorapomorphine ([3H]NPA) to the high affinity state of the pituitary D-2 receptor. The increase in [3H]NPA binding is due to both an increase in binding capacity (Bmax) and a decrease in the dissociation constant (KD). Monovalent cations have no effect on agonist binding either in the presence or absence of divalent cations. Neither divalent nor monovalent cations exert any effects on the binding of the antagonist, [3H]spiroperidol to pituitary D-2 receptors. Modification of sulfhydryl groups by N-ethylmaleimide and p-hydroxymercuribenzoate inactivates both [3H]NPA and [3H]spiroperidol binding; however, [3H]NPA binding exhibits a 50-fold greater sensitivity to N-ethylmaleimide. Inactivation of both [3H]NPA and [3]spiroperidol binding by N-ethylmaleimide and p-hydroxymercuribenzoate results in a diminished binding capacity for both radioligands. The inactivation of [3H] spiroperidol-binding by N-ethylmaleimide and p-hydroxymercuribenzoate can be protected against by occupying the receptor site with either antagonists or agonists, however, such treatments do not protect against inactivation of [3H]NPA binding. The effects of selectively decreasing the receptor subunit concentration on the proportions of high and low affinity agonist-binding states was additionally examined. A phenoxybenzamine-induced decrease of up to 63% of the receptor-binding sites has no effect on the proportions of agonist-binding states as detected with agonist/[3H]spiroperidol-competition curves. These results can all be incorporated into a two-step, three-component ternary complex model in which the second binding reaction appears to be under equilibrium restraint.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833284

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Effects of a chronic lithium treatment on cortical serotonin uptake sites and 5-HT1A receptors.

Authors:  M Carli; S Afkhami-Dastjerdian; T A Reader
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

Review 2.  Receptor-receptor interactions as an integrative mechanism in nerve cells.

Authors:  M Zoli; L F Agnati; P B Hedlund; X M Li; S Ferré; K Fuxe
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

Review 3.  Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.

Authors:  Jan-Peter van Wieringen; Jan Booij; Vladimir Shalgunov; Philip Elsinga; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-09       Impact factor: 3.000

4.  Occupancy of dopamine D₂ and D₃ and serotonin 5-HT₁A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography.

Authors:  Nicholas Seneca; Sjoerd J Finnema; István Laszlovszky; Béla Kiss; Attila Horváth; Gabriella Pásztor; Margó Kapás; István Gyertyán; Sándor Farkas; Robert B Innis; Christer Halldin; Balázs Gulyás
Journal:  Psychopharmacology (Berl)       Date:  2011-05-28       Impact factor: 4.530

5.  G protein dependent alterations in [125I]iodocyanopindolol and +/- cyanopindolol binding at 5-HT1B binding sites in rat brain membranes.

Authors:  K Ariani; M W Hamblin; G L Tan; C A Stratford; R D Ciaranello
Journal:  Neurochem Res       Date:  1989-09       Impact factor: 3.996

6.  Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain.

Authors:  M P Kung; S Chumpradit; D Frederick; S Garner; K D Burris; P B Molinoff; H F Kung
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-12       Impact factor: 3.000

7.  [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.

Authors:  M Carli; S Afkhami-Dastjerdian; T A Reader
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

8.  Differential susceptibility to ethanol and amphetamine sensitization in dopamine D3 receptor-deficient mice.

Authors:  Sarah Jane Harrison; José N Nobrega
Journal:  Psychopharmacology (Berl)       Date:  2008-12-19       Impact factor: 4.530

9.  Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.

Authors:  T A Reader; E Molina-Holgado; K M Dewar
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

10.  Specific [3H]raclopride binding to neostriatal dopamine D2 receptors: role of disulfide and sulfhydryl groups.

Authors:  T A Reader; E Molina-Holgado; L Lima; S Boulianne; K M Dewar
Journal:  Neurochem Res       Date:  1992-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.